In breast cancer, stabilization of mitochondrial glutaminase (GLS) by SIRT5-mediated desuccinylation leads to enhanced proliferation and survival, serving substrates for numerous metabolic pathways, correlating to poorer breast cancer prognosis when found overexpressed [59]. The gene discussed is SIRT5; the disease is breast cancer.